Skin cancer

Related records

Broader conditions (12)

• Cancer
• Cancer or benign tumor
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Human disease
• Integumentary system cancer
• Integumentary system disorder
• Neoplasm
• Neoplastic disease or syndrome
• Skin disorder
• Skin neoplasm

Narrower conditions (132)

• Acantholytic squamous cell skin carcinoma
• Acral lentiginous melanoma
• Adamantinoid basal cell epithelioma
• Amelanotic skin melanoma
• Anal margin basal cell carcinoma
• Anal margin carcinoma
• Anal margin squamous cell carcinoma
• Apocrine adenocarcinoma
• Apocrine sweat gland cancer
• Balloon cell malignant melanoma
• Basosquamous carcinoma
• Borst-Jadassohn intraepidermal carcinoma
• Bowen disease of the skin
• Breast apocrine carcinoma
• Breast malignant eccrine spiradenoma
• CD4+/CD56+ hematodermic neoplasm
• Ceruminous carcinoma
• Cervical adenoid basal carcinoma
• Clear cell squamous cell skin carcinoma
• Cutaneous adenocystic carcinoma

Trials (293)

• 3D Printed Rigid Bolus Versus Silicone Bolus for Treatment of Tumors Involving the Skin: A Comparative Study
• A Beta-only IL-2 ImmunoTherapY Study
• A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
• A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
• A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
• A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
• A Model for Genetic Susceptibility: Melanoma
• A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
• A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
• A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
• A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
• A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
• A Randomized Controlled Trial Comparing Sutures vs Staples for High Tension Closures
• A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
• A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
• A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
• A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
• ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
• Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Approved drugs (6)

• Avobenzone
• Dimethicone
• Octinoxate
• Salicylic acid
• Titanium dioxide
• Zinc oxide

Drugs in development (49)

• Acetaminophen Phase 3
• Aldesleukin Phase 3
• Atezolizumab Phase 1
• Avelumab Phase 2
• Capecitabine Phase 2
• Carboplatin Phase 3
• Cemiplimab Phase 2
• Cetuximab Phase 2
• Cholecalciferol Phase 1
• Cisplatin Phase 3
• Cobimetinib Phase 1
• Cyclophosphamide Phase 2
• Cyclosporine Phase 3
• Dacarbazine Phase 3
• Diclofenac Phase 2
• Diclofenac sodium Phase 2
• Durvalumab Phase 1
• Eflornithine hydrochloride Phase 2
• Erlotinib Phase 2
• Erlotinib hydrochloride Phase 1

Other linked drugs (3)

• Imiquimod
• Rasagiline
• UAB-30